For healthcare professionals. This information does not replace clinical judgement in the individual case; the current summary of product characteristics and the guidelines cited are authoritative.
Medically reviewed: Dr. med. univ. Daniel Pehböck, DESA, 01.11.2026
Anaphylaxis: Severity grades, Initial measures, If there is no improvement, Aftercare – concise for emergency, anaesthesia and intensive care teams, with sources and medically reviewed.
What the chapter covers
- Severity grades
- Initial measures
- If there is no improvement
- Aftercare
Complete in the app
Weight-based doses in mg and ml, tables, algorithms and calculators – also offline, on phone, tablet and PC. Try full access free for 7 days.
Drugs in this chapter
Sources and guidelines
- Lott C et al. European Resuscitation Council Guidelines 2025: Special Circumstances in Resuscitation. Resuscitation 2025;215 Suppl 1:110753.
- Djakow J, Turner NM, Skellett S et al. European Resuscitation Council Guidelines 2025 Paediatric Life Support. Resuscitation 2025;215 Suppl 1:110767.
- S2k-Leitlinie Akuttherapie und Management der Anaphylaxie (AWMF 061-025), Ring J et al., Allergo J Int 2021;30:1–25.
- Australasian Society of Clinical Immunology and Allergy (ASCIA). Positioning in Anaphylaxis bzw. ASCIA Guidelines.
- Cardona V, Ansotegui IJ, Ebisawa M et al. World Allergy Organization Anaphylaxis Guidance 2020. World Allergy Organ J 2020;13(10):100472, Tabelle 2 (klinische Kriterien.
- Summaries of product characteristics of authorised products – product and section for each dose in the app.